Cargando…
An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience
OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448559/ https://www.ncbi.nlm.nih.gov/pubmed/37074225 http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3 |
_version_ | 1785094762179592192 |
---|---|
author | Denkboy Öngen, Yasemin Özemri Sağ, Şebnem Temel, Şehime Gülsün Eren, Erdal |
author_facet | Denkboy Öngen, Yasemin Özemri Sağ, Şebnem Temel, Şehime Gülsün Eren, Erdal |
author_sort | Denkboy Öngen, Yasemin |
collection | PubMed |
description | OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay. The aim of this study was to evaluate and present all endocrinological findings of patients with 22q11.2 DS from a single center. METHODS: All participants had confirmed 22q11.2 DS by fluorescence in situ hybridization with hypoparathyroidism. Data were retrieved by retrospective review of patient records. RESULTS: A total of 17 patients were reviewed. On physical examination, all patients had similar dysmorphic features. The median age at diagnosis was 45 days (1 day-13 years). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dL, phosphorus was 6.2±1.1 mg/dL, and median parathyroid hormone (PTH) was 11.5 (3.7-47.6) ng/L. Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between patients with permanent or transient hypoparathyroidism regarding gender, age at diagnosis, calcium, phosphorus, and PTH levels. However, vitamin D levels were significantly lower in the transient group (p=0.036). During follow-up, short stature, obesity, and type 2 diabetes mellitus were absent. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Despite there being no pathological short stature, final stature was shorter than the general population (mean height standard deviation score: -0.94±0.83). CONCLUSION: Hypocalcemia may be detected during acute illness in some cases where hypocalcemia appears at later ages. There was no significant difference between permanent and transient hypoparathyroidism cases in terms of PTH level. Recognition of the more specific facial findings is important to trigger investigation of genetic variants, additional anomalies, and for follow-up. |
format | Online Article Text |
id | pubmed-10448559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104485592023-09-01 An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience Denkboy Öngen, Yasemin Özemri Sağ, Şebnem Temel, Şehime Gülsün Eren, Erdal J Clin Res Pediatr Endocrinol Original Article OBJECTIVE: 22q11.2 deletion syndrome (22q11.2 DS) is the most common chromosomal microdeletion disorder. Associated problems in 22q11.2 DS may include cardiac abnormalities, immune dysfunction, facial dysmorphism, with endocrine, genitourinary and gastrointestinal problems, and developmental delay. The aim of this study was to evaluate and present all endocrinological findings of patients with 22q11.2 DS from a single center. METHODS: All participants had confirmed 22q11.2 DS by fluorescence in situ hybridization with hypoparathyroidism. Data were retrieved by retrospective review of patient records. RESULTS: A total of 17 patients were reviewed. On physical examination, all patients had similar dysmorphic features. The median age at diagnosis was 45 days (1 day-13 years). Most cases (64.7%, 11/17) were diagnosed with hypoparathyroidism incidentally after routine tests. At the time of diagnosis, mean calcium was 7.04±0.80 mg/dL, phosphorus was 6.2±1.1 mg/dL, and median parathyroid hormone (PTH) was 11.5 (3.7-47.6) ng/L. Transient hypoparathyroidism was detected in five cases (29.4%). There was no significant difference between patients with permanent or transient hypoparathyroidism regarding gender, age at diagnosis, calcium, phosphorus, and PTH levels. However, vitamin D levels were significantly lower in the transient group (p=0.036). During follow-up, short stature, obesity, and type 2 diabetes mellitus were absent. Thyroid autoantibodies were detected in two patients with normal thyroid function tests. Despite there being no pathological short stature, final stature was shorter than the general population (mean height standard deviation score: -0.94±0.83). CONCLUSION: Hypocalcemia may be detected during acute illness in some cases where hypocalcemia appears at later ages. There was no significant difference between permanent and transient hypoparathyroidism cases in terms of PTH level. Recognition of the more specific facial findings is important to trigger investigation of genetic variants, additional anomalies, and for follow-up. Galenos Publishing 2023-09 2023-08-23 /pmc/articles/PMC10448559/ /pubmed/37074225 http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3 Text en ©Copyright 2023 by Turkish Pediatric Endocrinology and Diabetes Society | The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License. |
spellingShingle | Original Article Denkboy Öngen, Yasemin Özemri Sağ, Şebnem Temel, Şehime Gülsün Eren, Erdal An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title | An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title_full | An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title_fullStr | An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title_full_unstemmed | An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title_short | An Endocrinological Perspective on 22q11.2 Deletion Syndrome: A Single-center Experience |
title_sort | endocrinological perspective on 22q11.2 deletion syndrome: a single-center experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448559/ https://www.ncbi.nlm.nih.gov/pubmed/37074225 http://dx.doi.org/10.4274/jcrpe.galenos.2023.2022-11-3 |
work_keys_str_mv | AT denkboyongenyasemin anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT ozemrisagsebnem anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT temelsehimegulsun anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT erenerdal anendocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT denkboyongenyasemin endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT ozemrisagsebnem endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT temelsehimegulsun endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience AT erenerdal endocrinologicalperspectiveon22q112deletionsyndromeasinglecenterexperience |